Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2024/03/05/2840482/0/en/AIDS-Clinical-Trial-Group-Presents-Results-from-Phase-1-Study-of-ModeX-Trispecific-Antibody-for-the-Treatment-and-Prevention-of-HIV.html
https://www.globenewswire.com//news-release/2024/02/27/2836449/0/en/OPKO-Health-Reports-Fourth-Quarter-2023-Business-Highlights-and-Financial-Results.html
https://www.globenewswire.com//news-release/2024/02/22/2834071/0/en/OPKO-Health-to-Report-Fourth-Quarter-2023-Financial-Results-on-February-27-2024.html
https://www.globenewswire.com//news-release/2024/01/09/2806678/0/en/OPKO-Health-Announces-Closing-of-Private-Offering-of-230-Million-Convertible-Senior-Notes-Due-2029-including-Full-Exercise-of-Initial-Purchaser-s-Option-to-Purchase-Additional-Note.html
https://www.globenewswire.com//news-release/2024/01/08/2805414/0/en/OPKO-Health-to-Present-at-the-42nd-Annual-J-P-Morgan-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2024/01/03/2803661/0/en/OPKO-Health-Announces-Private-Offering-of-Convertible-Senior-Notes-Due-2029.html
https://www.globenewswire.com//news-release/2023/11/06/2774514/0/en/OPKO-Health-Reports-Third-Quarter-2023-Business-Highlights-and-Financial-Results.html
https://www.globenewswire.com//news-release/2023/11/02/2772514/0/en/New-Clinical-Data-on-OPKO-Health-s-RAYALDEE-ER-Calcifediol-Presented-at-Kidney-Week-2023.html
https://www.globenewswire.com//news-release/2023/10/31/2770093/0/en/OPKO-Health-to-Report-Third-Quarter-2023-Financial-Results-on-November-6-2023.html
https://www.globenewswire.com//news-release/2023/10/25/2766975/0/en/OPKO-Health-to-Present-New-Clinical-Data-on-Rayaldee-ER-Calcifediol-at-Kidney-Week-2023.html